“De-risking the commercialisation of Health-Tech innovations”
We provide expert advice on the commercialisation of biotech and medtech innovations, beyond the Regulatory Clearances, i.e. Health Economics, Reimbursement, Distribution and most importantly Adoption. Med2Mark thoroughly assesses the commercial value of Health-Tech innovations before significant investments are committed.
We are an international boutique Consulting Practice with over twenty years’ experience in the commercialisation of Biotech and Medtech innovations in the USA, Europe, Asia and Australia
Company Details
- Employees
- 1
- Founded
- -
- Address
- 49 Studley Park Rd, Melbourne,victoria 3101,australia
- Industry
- Medical Device
- Website
- med2mark.com
- Keywords
- Medical technologies, Biotechnologies, Commercialisation, Reimbursement, Distribution, Adoption, Product launch, Key Opinion Leaders, Market development, Strategic planning, Private Equity, Venture Capital, Start-up, Sales incentives, Strategic alliances, Management KPIs, Health economics.
- HQ
- Melbourne, Victoria
Med2mark Questions
Med2Mark's website is med2mark.com
Med2Mark's LinkedIn profile is https://au.linkedin.com/company/med2mark
Med2Mark has
1 employees.
View email and phone details for 1
employees at Med2Mark.
Med2Mark's industry is
Medical Device
Med2Mark's top competitors are
Med2me,
Ipq Analytics,
Liberty Biosecurity, Llc,
Rubens Technologies,
Synbionz,
Kinsae,
Nuroflux,
Storymd,
Novotech,
Brainvalue Neurotech.
Med2Mark's categories are Medical Device
Med2Mark's founding year is 2011
